1. Gross Law Firm announces class action against Biohaven Ltd. (BHVN). 2. Allegations include misleading claims about drug prospects. 3. Class period from March 24, 2023, to May 14, 2025. 4. Shareholders encouraged to register for potential recovery. 5. Deadline to register as lead plaintiff is September 12, 2025.
The allegations suggest serious misrepresentation, historically causing stock declines post-legal issues.
The lawsuit can significantly affect investor sentiment and stock price due to legal risks.
Ongoing legal ramifications can impact BHVN's valuation and investor trust for years.
NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE:BHVN).
Shareholders who purchased shares of BHVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=161232&from=4
CLASS PERIOD: March 24, 2023 to May 14, 2025
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) The company's product candidate, troriluzole's regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole's regulatory approval for this indication, were overstated; (ii) BHV-7000's efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated; (iii) all the foregoing, once revealed, was likely to have a significant negative impact on Biohaven's business and financial condition; and (iv) as a result, defendants' public statements were materially false and misleading at all relevant times.
DEADLINE: September 12, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=161232&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of BHVN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 12, 2025. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download multimedia:https://www.prnewswire.com/news-releases/biohaven-ltd-sued-for-securities-law-violations--investors-should-contact-the-gross-law-firm-for-more-information--bhvn-302529609.html
SOURCE The Gross Law Firm